Is there evidence for effectiveness of transcranial magnetic stimulation in the treatment of psychiatric disorders?

Transcranial magnetic stimulation (TMS), since its introduction in 1985, has been studied for its efficacy in different psychiatric disorders. It has been touted to be an effective treatment modality for major depression, obsessive compulsive disorder, Tourette syndrome, and in reducing auditory hallucinations in patients with schizophrenia. In this article, the authors outline the research and evidence toward the efficacy of TMS in psychiatry.

Use of antipsychotics in the treatment of post-traumatic stress disorder.

Post-traumatic stress disorder (PTSD) is a severe and disabling psychiatric syndrome. With the advent of selective serotonin reuptake inhibitors (SSRIs), major strides have been made in the realms of pharmacotherapy. The multiplicity of symptom complex includes specific target symptoms, such as intrusiveness, aggression, sleep disturbances, and co-existing psychotic symptoms.